Rucha Patil: Advancing Haemostasis Through Science, Collaboration and Innovation at NHU 2026
Rucha Patil, Scientist at Department of Haemostasis and Thrombosis, ICMR- National Institute of Immunohaematology, shared a post on LinkedIn:
“NHU 2026 | Advancing Haemostasis Through Science, Collaboration and Innovation
The 15th National Haemostasis Update (NHU) 2026, held on 1–2 August 2026 in Bengaluru, Organised by the Indian Association for Haemophilia and Allied Disorders (IAHAD) brought together clinicians, nurses, physiotherapists, researchers, and allied healthcare professionals from across India with a shared vision of advancing care for people with haemophilia and other bleeding disorders.
The conference concluded on an exceptionally proud note, with three outstanding laboratory research studies from our team being awarded the Best Poster Awards:
- A Novel Emicizumab-Compatible Lateral Flow Immunoassay for Rapid Detection of Factor VIII Inhibitors
(Rucha Patil, Sharda Shanbhag, Sweta Kaskar, Moni Singh) - Immunogenetic Basis of Factor VIII Inhibitor Development in Severe Haemophilia A Patients: Integrated Analysis of Immune Cell Profiling, Cytokine Signatures, Immune Gene Polymorphisms & Whole Exome Sequencing (sharda shanbhag, Karishma Vyas, Bipin Kulkarni, Rucha Patil)
- Prenatal Insight into a Rare Dual-Lineage Compound Heterozygous Female Foetus Affected by Haemophilia A(Karishma Vyas, Nikesh Kawankar, Babita Phartyal, Rucha Patil, Bipin Kulkarni, Sharda Shanbhag)
Adding another moment of pride, the Best Oral Presentation Award was for:
Real-World Clinical Experience with Very Low-Dose Emicizumab Prophylaxis in Hemophilia A: ‘A Single-Centre Study from a Tertiary Care Institute’ a KEM-ICMR study (Kalpita Pai, Rucha Patil, Kirti Patil, Jai Juverkar, Sayali Rasal)
These recognitions reflect the dedication, teamwork, and commitment of our group towards advancing innovative diagnostics, precision medicine, and improved therapeutic strategies in haemophilia care.”
Stay updated with Hemostasis Today.
-
Aug 9, 2026, 02:26Exploring the Future of Rare Bleeding Disorder Treatment at EHC 2026
-
Aug 9, 2026, 02:08Shivam Bansal: Targeting Chemotherapy-Induced Thrombocytopenia in Children with Romiplostim
-
Aug 9, 2026, 01:48Paolo Zamboni: Treating Post-Thrombotic Syndrome by Eliminating Venous Reflux
-
Aug 8, 2026, 20:37Tammuella Chrisentery-Singleton: What Comes Next for Hemophilia Care With Non-Factor Therapies?
-
Aug 8, 2026, 20:36Michelle Cha: The Evolving Role of Nurse Coordinators in Hemophilia Gene Therapy
-
Aug 8, 2026, 20:35Benjamin Schumacher: The Future of Holistic Haemophilia A Care
-
Aug 8, 2026, 20:33Delilah F.: March Is Blood Clot Awareness Month
-
Aug 8, 2026, 20:31Jackie Maybin: Top 10 Research Priorities for Problematic Menstrual Bleeding in the UK
-
Aug 8, 2026, 17:02Mohammed Murad Hossain: Highlights from the 2nd Haematology and HSCT Workshop in Dhaka